Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 6451 to 6465 of 7690 results

  1. Vagus nerve stimulation for treatment-resistant depression (IPG330)

    This guidance has been updated and replaced by NICE interventional procedures guidance 679.

  2. Extracranial to intracranial bypass for intracranial atherosclerosis (IPG348)

    This guidance has been updated and replaced by NICE interventional procedures guidance 596.

  3. Laparoscopic radical hysterectomy for early stage cervical cancer (IPG338)

    This guidance has been updated and replaced by NICE interventional procedures guidance 686.

  4. Low-intensity pulsed ultrasound to promote fracture healing (IPG374)

    This guidance has been updated and replaced by:

  5. External aortic root support in Marfan syndrome (IPG394)

    This guidance has been updated and replaced by NICE interventional procedures guidance 724.

  6. Off-pump coronary artery bypass (OPCAB) (IPG35)

    This guidance has been updated and replaced by NICE interventional procedure guidance 377.

  7. Endoscopic saphenous vein harvest for coronary artery bypass grafting (IPG343)

    This guidance has been updated and replaced by NICE interventional procedure guidance 494.

  8. Health app: ChatHealth communication platform in school nursing services (MIB130)

    The health app briefing on ChatHealth communication platform in school nursing services has been withdrawn.

  9. Daylight for treating generalised anxiety disorder in adults (MIB309)

    August 2023: This medtech innovation briefing (MIB) has been withdrawn at the company’s request as the evidence for the technology has moved on and the company expect to seek a NICE guidance output in due course.

  10. Erythrocyte encapsulated asparaginase for treating acute lymphoblastic leukaemia [ID864]

    Discontinued [GID-TA10047]

  11. SeQuent Please Neo balloon catheter for in-stent coronary restenosis - update of MTG1 (discontinued)

    Discontinued [GID-MT516]

  12. Abicipar pegol for treating wet age-related macular degeneration ID1533

    In development [GID-TA10511] Expected publication date: TBC

  13. Durvalumab for treating metastatic urothelial bladder cancer after chemotherapy [ID1172]

    Discontinued [GID-TA10394]